Skip to main content
Extra Extra

New weight-loss shot appears to outperform other obesity drugs on market

4 sources|Diversity: 95%|
Left (2) Center (1) Right (1)

Left(2)

The GuardianAMay 21, 4:50 PM

New weight-loss shot appears to outperform other obesity drugs on market

Eli Lilly says participants in a sizable trial of retatrutide lost much more weight compared to other weight-loss drugs A new weight-loss drug has helped participants in a sizable trial lose much more

New York TimesAMay 21, 10:45 AM

Experimental Drug Yields Dramatic Weight Loss

People who got the injection, retatrutide, lost 28 percent of their body weight on average after 80 weeks, Eli Lilly said.

Center(1)

The HillBMay 21, 7:04 PM

New obesity drug from Lilly delivers major weight loss

An investigational obesity drug from Eli Lilly cleared important end points in a late-stage trial, the company said Thursday, by helping patients lose up to 30 percent of their body weight.  Lilly sai

Right(1)

Just the NewsCMay 21, 12:00 AM

Ely Lilly's new weight-loss drug shows average 85-pound loss in late-stage clinical trials

The results match those of bariatric surgery, which helps those who have the surgery lose 25% to 35% of their total body weight.

Get this analysis in your inbox

The Daily Spectrum: one email, three perspectives on the day's biggest stories.

Free forever. Unsubscribe anytime. No spam.

Back to Compare